✦ LIBER ✦
Primary prophylaxis with granulocyte colony-stimulating factor (GCSF) reduces the incidence of febrile neutropenia in patients with non-Hodgkin lymphoma (NHL) receiving CHOP chemotherapy treatment without adversely affecting their quality of life: cost–benefit and quality of life analysis
✍ Scribed by Sophie Lee, Angela Knox, Irene S. L. Zeng, Christin Coomarasamy, Hilary Blacklock, Samar Issa
- Book ID
- 118787301
- Publisher
- Springer-Verlag
- Year
- 2012
- Tongue
- English
- Weight
- 156 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0941-4355
No coin nor oath required. For personal study only.